Ketamine, PCP - reduces the function of NMDA receptor,RBM12 - Loss of function, ErbB4 KO - Loss of function
Psychosis
Genotype
Ketamine, PCP, RBM12, and ErbB4 Knockout
Mechanism
Ketamine, PCP - reduces the function of NMDA receptor,RBM12 - Loss of function, ErbB4 KO - Loss of function
Phenotype
Hyperlocomotion, Seizures, Cognitive impairment, Social isolation, Repetitive behavior, Impulsivity, Psychosis
Biomarker
Tau protein, NfL, NRG1, TNF-α
Gene Expression Markers
HTR2A, ERBB4, IL-6, GRIN1, RBM12
Physiology Changes
EEG - Baseline gamma activity, Reduced slow wave sleep, Abnormal REM pattern, Event related Potential
Histology Grading Endpoint
Synaptic changes, Cortical dysfunction, Reduced white matter integrity



